Science by Press Release | The Epoch Times

0
3858

Commentary

We’ve been subjected to an extraordinary display of the integration of finance and the medical industry that came in the form of a press release. Based on nothing other than this release, the stock of the company worth $54 billion soared 170 percent. That’s some serious marketing power on a level not available to any other industry.

The company in question is the pharmaceutical maker Moderna, which specializes in mRNA technology that many have said for decades represents the future of medicine. Its first deployment—and the first product ever produced by Moderna—came with the release of the COVID shot in 2020.

That too was announced in a press release advertising a 95 percent effectiveness rate, a number many people confused with a pledge that 95 percent of the people taking the shot would not get COVID. The company never tested for that at all. It was not part of the…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here